Please assess the completion status of the following clinical trial:

Trial Title: Terlipressin + Albumin Versus Midodrine + Octreotide in the Treatment of Hepatorenal Syndrome

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2/PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients with cirrhosis and diagnosis of HRS type 1 or 2,serum creatinine \> 2.5 mg/dl~Exclusion Criteria:~* Diagnosis of HCC with a staging beyond the Milan Criteria di Milano~* Septic shock (systolic arterial pressure \< 90 mmHg~* Significant heart or respiratory failure~* Peripheral arteriophaty clinically significant~* Previous heart stroke or significant alteration of the ECG

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): Fifty patients with cirrhosis and HRS will be randomly assigned to arm 1.
- 2 (Type: EXPERIMENTAL): Fifty patients with cirrhosis and HRS will be randomly assigned to arm 2.

Based on this trial design, predict the completion outcome and termination type (if applicable).